Back to Search
MARLENE MARON, PH.D.
PH.D.
Clinical Psychologist
NPI: 1568491371IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
048-0000536(VT)
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1991
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.
PMID 29604289·Am J Med·2018
2-rct
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
PMID 27450876·JACC Cardiovasc Imaging·2016
1-meta
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
PMID 25406305·Circulation·2015
4-observational
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
PMID 25092278·Circulation·2014
4-observational
Spironolactone for heart failure with preserved ejection fraction.
PMID 25006726·N Engl J Med·2014
8-other
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
PMID 24998133·J Am Coll Cardiol·2014
6-review
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
PMID 15313958·Circulation·2004
8-other
Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
PMID 15531767·N Engl J Med·2004
3-trial
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
PMID 14993121·Circulation·2004
7-preclinical
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
PMID 14517164·Circulation·2003
3-trial
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
PMID 12668699·N Engl J Med·2003
3-trial
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
PMID 11171784·Circulation·2001
7-preclinical
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death.
PMID 10636256·J Am Coll Cardiol·2000
8-other
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.
PMID 11094035·Circulation·2000
3-trial
Impact of midwives' training on postnatal depression screening in the first week post delivery: a quality improvement report.
PMID 19211177·Midwifery·2010
8-other
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
PMID 19589434·J Am Coll Cardiol·2009
8-other
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
PMID 19307481·Circulation·2009
8-other
Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
PMID 19528341·Circulation·2009
5-case
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
PMID 19589431·J Am Coll Cardiol·2009
6-review
Beta-adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure.
PMID 19592457·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 COLCHESTER AVE, PATRICK 405
BURLINGTON, VT 05401 - Phone
- (802) 847-4880
Quick Facts
- NPI
- 1568491371
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile